HNB
GPCR icon

Huntington National Bank’s Structure Therapeutics GPCR Stock Holding History

Huntington National Bank’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$96 Hold
2
– – ﹤0.01% 2615
2025
Q4 		$139 Hold
2
– – ﹤0.01% 2471
2025
Q3 		$56 Hold
2
– – ﹤0.01% 2838
2025
Q2 		$41 Hold
2
– – ﹤0.01% 3050
2025
Q1 		$35 Hold
2
– – ﹤0.01% 3170
2024
Q4 		$54 Hold
2
– – ﹤0.01% 2951
2024
Q3 		$88 Hold
2
– – ﹤0.01% 2756
2024
Q2 		$79 Buy
+2
New +$82 ﹤0.01% 2749

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Huntington National Bank's GPCR Position: Q1 2026 in Review

Huntington National Bank held its Structure Therapeutics (GPCR) position steady in Q1 2026 at 2 shares worth $96. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Huntington National Bank first reported a position in GPCR in Q2 2024 and has held it in 8 quarters since. The position peaked at $139 in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Huntington National Bank held 2 shares of Structure Therapeutics worth $96 as of Q1 2026.
  • Huntington National Bank left its Structure Therapeutics share count unchanged in Q1 2026.
  • Structure Therapeutics made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2615 holding.
  • Huntington National Bank first reported a position in Structure Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • Huntington National Bank's Structure Therapeutics position peaked at $139 in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.